#1506 on the rich list of 14,644 insiders
Michael Ackermann
Director at Tarsus Pharmaceuticals. Based in Irvine, California.
$100M
in disclosed stock, +$641K (+0.65%) today
Live prices, last trade 3:01 PM ET
- Rank
- 1506th of 14,644
- Companies held
- 1
- Largest holding
- TARS, 100.0% of total
- Latest SEC filing
- Jun 15, 2022
What the $100M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals TARS Common Stock | Directly | 1,208,273 | $76.44 | $92.4M | 92.4% | Form 4, Jun 15, 2022 |
| Tarsus Pharmaceuticals TARS Common Stock | Through the Ackermann & Elmen-Gruys Trust Dated June 24, 2014 | 100,000 | $76.44 | $7.6M | 7.6% | Form 4, Jun 15, 2022 |
Share counts are the amounts Michael Ackermann reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1503 | Matthew Kalish Director, DraftKings. Boston, MA | $100M |
| 1504 | Veronique Lecault Chief Operating Officer, AbCellera Biologics | $100M |
| 1505 | Anat Ashkenazi EVP & CFO, Eli Lilly and. Mountain View, CA | $100M |
| 1506 | Michael Ackermann Director, Tarsus Pharmaceuticals. Irvine, CA | $100M |
| 1507 | Keith Liddell Director, Lifezone Metals | $99.8M |
| 1508 | William M. Hickey III Co-Chief Executive Officer, Permian Resources. Midland, TX | $99.8M |
| 1509 | James H. Walter Co-Chief Executive Officer, Permian Resources. Midland, TX | $99.8M |
Other Tarsus Pharmaceuticals insiders
All TARS insiders- Bobak R. Azamian$131MPresident/CEO and Board Chair. #1232 overall
- William J. Link Phd$8.0MDirector. #8118 overall
- Seshadri Neervannan$6.0MChief Operating Officer. #12733 overall
- Leonard Greenstein$2.0MChief Financial Officer. #13967 overall
- Bhaskar Chaudhuri$891KDirector. #4267 overall
- David E. I. Pyott$838KDirector. #9616 overall
Questions
How much stock does Michael Ackermann own?
Michael Ackermann holds $100,004,388 in listed stock based on SEC filings and current prices, mostly Tarsus Pharmaceuticals (TARS). That ranks 1506th on the Stock Rich List.
Is this Michael Ackermann's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.